MeCure Industries PLC, a leading pharmaceutical manufacturer in Nigeria, has announce the successful and full redemption of its N3 billion Senior Secured Bond (Series 1) issued under its N20 billion Debt Issuance Programme.
The bond, originally issued on 14th May 2021, marked the company’s debut transaction in the Nigerian capital market. The full repayment underscores MeCure’s strong financial discipline, robust cash flow management, and commitment to meeting its obligations to investors.
Ifedamola Oluwasegun, chief financial officer at MeCure Industries, said the successful redemption of the Series 1 bond is a significant achievement for the organisation.
“It reflects not only our financial resilience but also the confidence that the capital markets placed in us during our debut issuance,” Oluwasegun said, while speaking on the milestone.
“We are proud to have honoured this obligation in full and on schedule,” he noted.
“The company delivered a solid performance in 2025, driven by operational efficiency, expanded market reach, and continued investment in manufacturing capabilities,” he added.
Looking ahead, he noted that the organisation is optimistic of the year, saying “with a strong pipeline of opportunities that will support sustainable growth and long-term value creation.”
Since its issuance, the bond has played a key role in supporting MeCure’s strategic initiatives, including capacity expansion, product development, and strengthening its distribution network across Nigeria and export markets.
The milestone also reinforces MeCure’s position as a credible and disciplined issuer in the Nigerian capital market, setting a strong foundation for future engagements with investors as the company continues to pursue its growth ambitions.
Join BusinessDay whatsapp Channel, to stay up to date
Open In Whatsapp
